Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.

NCT07394946 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer

Interventions

DRUG: Letrozole

Sponsor

Cancer Care Hospital & Research Centre Foundation, Lahore